(Q38306167)

2 September 2017

Transcriptional regulation by infliximab therapy in Kawasaki disease patients with immunoglobulin resistance (English)

1 reference

2 September 2017

1 reference

Yoshihito Ogihara

1

1 reference

2 September 2017

Shohei Ogata

2

1 reference

2 September 2017

Keiko Nomoto

3

1 reference

2 September 2017

Takasuke Ebato

4

1 reference

2 September 2017

Kayoko Sato

5

1 reference

2 September 2017

Kenichi Kokubo

6

1 reference

2 September 2017

Hirosuke Kobayashi

7

1 reference

2 September 2017

Masahiro Ishii

8

1 reference

2 September 2017

language of work or name

English

0 references

publication date

25 June 2014

1 reference

2 September 2017

1 reference

2 September 2017

76

1 reference

2 September 2017

3

1 reference

2 September 2017

287-293

1 reference

https://scigraph.springernature.com/pub.10.1038/pr.2014.92

2 September 2017

0 references

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.92

Infliximab treatment for refractory Kawasaki syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.92

Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.92

Infliximab for intravenous immunoglobulin resistance in Kawasaki disease: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.92

Infliximab reduces the cytokine-mediated inflammation but does not suppress cellular infiltration of the vessel wall in refractory Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.92

Circulating interleukin 17 is increased in the acute stage of Kawasaki disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.92

Transcript abundance patterns in Kawasaki disease patients with intravenous immunoglobulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.92

Gene-expression patterns reveal underlying biological processes in Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.92

Up-regulation of NOD1 and NOD2 through TLR4 and TNF-alpha in LPS-treated murine macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.92

Control of matrix metalloproteinase catalytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.92

Polymorphism of matrix metalloproteinase-3 promoter gene as a risk factor for coronary artery lesions in Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.92

Transforming growth factor-beta signaling pathway in patients with Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.92

The role of TGF-β and myofibroblasts in the arteritis of Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.92

The WAP protein Trappin-2/Elafin: a handyman in the regulation of inflammatory and immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.92

Tumor necrosis factor induces matrix metalloproteinases in cardiomyocytes and cardiofibroblasts differentially via superoxide production in a PI3Kgamma-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.92

Important role of CCR2 in a murine model of coronary vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.92

Geometric method for measuring body surface area: a height-weight formula validated in infants, children, and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.92

New equations and a critical appraisal of coronary artery Z scores in healthy children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.92

Clinical score and transcript abundance patterns identify Kawasaki disease patients who may benefit from addition of methylprednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.92

Summaries of Affymetrix GeneChip probe level data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.92

WikiPathways: building research communities on biological pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.92

Unique activation status of peripheral blood mononuclear cells at acute phase of Kawasaki disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.92

Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.92

Serum levels of p60 soluble tumor necrosis factor receptor during acute Kawasaki disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.92

TNF- Is Necessary for Induction of Coronary Artery Inflammation and Aneurysm Formation in an Animal Model of Kawasaki Disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.92

Spotlight on infliximab in Crohn disease and rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.92

Circulating interleukin-1 beta in patients with Kawasaki disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.92

Clinical application of rapid assay of serum interleukin-6 in Kawasaki disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.92

Genetic analysis of MMP gene polymorphisms in patients with Kawasaki disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.92

Blockage of TNF-α by infliximab reduces CCL2 and CCR2 levels in patients with rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.92

Sensitive assessment of activity of Takayasu's arteritis by pentraxin3, a new biomarker

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.92

Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.92

Dramatic decrease of circulating levels of monocyte chemoattractant protein-1 in Kawasaki disease after gamma globulin treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.92

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/PR.2014.92

1 reference

Dimensions Publication ID

2 September 2017

0 references

1 reference